Latest filing published 14 Dec 2015 for MOMENTA PHARMACEUTICALS INC, €7,523.
Insider track record
No signal scores available.
Michael Franken: trading record in brief
Michael Franken appears in our data through filings on Momenta Pharmaceuticals Inc shares, published by SEC (Form 4). Between 10 December 2013 and 11 December 2015, the trades on record add up to 9 filings.
The open-market record consists of 6 sales worth €459k, with no purchase. Outside the open market, there are 2 share grants and 1 option exercise. Since January 2015: no purchases and 5 sales on the market.
The newest entry dates from 14 December 2015: an open-market sale of €7,523, in Momenta Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael Franken
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 520 shares@ US$15.84Common StockSEC:0001179110-15-016196:0
- 513 shares@ US$18.92Common StockSEC:0001104659-15-065174:0
- 20,000 shares@ US$17.23Common StockSEC:0001179110-15-012119:0
- 20,000 shares@ US$22.36Common StockSEC:0001179110-15-012119:1
- 512 shares@ US$22.37Common StockSEC:0001179110-15-009761:0
- 512 shares@ US$14.71Common StockSEC:0001179110-15-004846:0
- 16,976 shares0Common StockSEC:0001179110-15-003036:0
- 2,047 shares@ US$12.29Common StockSEC:0001179110-14-018052:0
- 25,000 shares0Common StockSEC:0001179110-13-017774:0
9 of 9 declarations
